Increasing initiation of evidence-based weight loss treatment
越来越多地开始开展循证减肥治疗
基本信息
- 批准号:10735201
- 负责人:
- 金额:$ 61.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAdultAfrican AmericanAgeAppointmentBehavior TherapyBehavioralBlack raceBody Weight ChangesBody Weight decreasedBody mass indexCharacteristicsChronic DiseaseClinicClinicalCluster randomized trialCounselingDataDemographic FactorsDisparityDistressEducationEligibility DeterminationEnrollmentEnsureEquityEthnic OriginEvidence based treatmentFeedbackFrequenciesGenderGoalsIncomeIndividualInsurance CarriersInterventionInterviewLow incomeMaintenanceMediatorMethodsModelingObesityObesity EpidemicOutcomeParticipantPatientsPatternPopulationPopulation HeterogeneityPrimary CareProviderRaceRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceRiskSamplingScheduleSignal TransductionTestingUnited States Centers for Medicare and Medicaid ServicesWeightWeight maintenance regimenWomanWorkadult obesityarmcostdepressive symptomsdesigndiabetes prevention programeffectiveness testingevidence basefeasibility trialhigher educationimprovedintervention effectmenmortalitymotivational enhancement therapynovelobese patientsobesity treatmentparticipant enrollmentpilot trialpopulation healthprimary care clinicprimary care patientprimary care practiceprimary care providerprimary outcomerandomized, clinical trialsrecruitsecondary outcometooltreatment centertwo-arm studyuptakeusabilityweight loss interventionweight loss program
项目摘要
PROJECT SUMMARY/ABSTRACT
Comprehensive behavioral treatments are effective at promoting weight loss and improving clinical outcomes
among adults with obesity. However, a large majority of individuals with obesity never take the first step of
initiating these treatments (even when barriers to cost and access are reduced), severely limiting the
population impact of evidence-based weight management treatments. To address this challenge and take
advantage of growing access to comprehensive weight loss treatments, our team has developed a tool
designed to increase initiation of evidence-based behavioral weight loss treatments among eligible but non-
treatment seeking adults (“mobilization tool”). As part of this tool, patients answer brief questions and receive
automated, individually tailored feedback. This feedback targets empirically and theoretically relevant
constructs for treatment initiation using a Motivational Interviewing approach that supports patient autonomy.
The tool is completed by patients in the days prior to a scheduled primary care appointment and contains
explicit endorsement by patients’ primary care provider (PCPs), taking advantage of PCPs’ influence while not
relying on PCPs to initiate weight counseling. It is also designed to be low burden and high acceptability to
PCPs to facilitate dissemination, if effective. We previously conducted a cluster randomized feasibility pilot trial
to inform plans for a fully powered test of the effectiveness of the mobilization tool. The pilot showed that the
tool was highly usable, informative, and enjoyable; feasibility goals were met; and a signal of an effect was
observed. We are now prepared to conduct an adequately powered cluster randomized clinical trial to compare
the effects of the mobilization tool and a static treatment description (comparator tool), and to examine how
effects differ across key demographic factors. We will recruit and randomize PCPs (n=36) and patients with
obesity (n=828) who have an upcoming appointment with enrolled PCPs. All enrolled patients will complete
either the mobilization tool or the comparator tool, depending on their randomization arm, and will be informed
that they have free access to comprehensive weight loss treatment. We will compare the two study arms on
the proportion who initiate weight loss treatment (primary outcome), session attendance, and weight loss
outcomes at 6 months (secondary outcomes). Because weight loss programs historically have had lower
uptake by individuals who are men, Black/African American, younger, have lower income, and have lower
educational attainment, we will recruit a diverse population to allow for comparisons of effects across gender,
race, age, income, and education. If effective, the proposed mobilization tool could be disseminated within
primary care practices to increase the number of adults with obesity who initiate evidence-based weight loss
treatment, resulting in greater population weight loss and meaningful changes in population health.
项目总结/摘要
综合行为治疗在促进减肥和改善临床结果方面有效
在肥胖的成年人中。然而,绝大多数肥胖者从未迈出第一步,
启动这些治疗(即使成本和获取障碍减少),严重限制了
基于证据的体重管理治疗的人群影响。为了应对这一挑战,
随着越来越多的人获得全面的减肥治疗,我们的团队开发了一种工具,
旨在增加在符合条件但不符合条件的人群中开展循证行为减肥治疗的机会。
寻求治疗的成年人(“动员工具”)。作为该工具的一部分,患者回答简短的问题,
自动化、个性化的反馈。这种反馈的目标是经验和理论上相关的
使用支持患者自主性的动机访谈方法进行治疗启动的结构。
该工具由患者在预定的初级保健预约前几天完成,包含
患者的初级保健提供者(PCP)的明确认可,利用PCP的影响力,
依靠PCP来进行体重咨询。它还被设计成低负担和高可接受性,
如果有效,项目完成方案将促进传播。我们之前进行了一项群集随机可行性试点试验
为动员工具有效性的全面测试计划提供信息。飞行员表示,
工具的可用性、信息量和趣味性都很高;可行性目标得到满足;效果信号是
观察我们现在准备进行一项有充分把握度的随机分组临床试验,
动员工具和静态治疗描述(比较工具)的效果,并检查如何
影响因关键人口因素而异。我们将招募并随机分配PCP(n=36)和患者,
肥胖(n=828),即将与入组的PCP进行预约。所有入组患者将完成
动员工具或比较工具,取决于其随机分组,并将被告知
他们可以免费获得全面的减肥治疗。我们将比较两个研究组,
开始减肥治疗的比例(主要结局)、会议出席率和体重减轻
6个月时的结局(次要结局)。因为减肥计划在历史上有较低的
男性、黑人/非裔美国人、年轻人、收入较低的人以及
教育程度,我们将招募不同的人群,以比较不同性别的影响,
种族、年龄、收入和教育。如果有效,拟议的动员工具可在内部传播,
初级保健实践,以增加开始循证减肥的肥胖成年人的数量
治疗,导致更大的人口体重减轻和人口健康的有意义的变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Megan Apperson McVay其他文献
Megan Apperson McVay的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Megan Apperson McVay', 18)}}的其他基金
Preventing weight gain among those who decline behavioral weight loss treatment
防止拒绝行为减肥治疗的人体重增加
- 批准号:
10064248 - 财政年份:2020
- 资助金额:
$ 61.94万 - 项目类别:
Increasing uptake of behavioral weight loss programs among primary care patients
初级保健患者越来越多地接受行为减肥计划
- 批准号:
9458792 - 财政年份:2015
- 资助金额:
$ 61.94万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 61.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 61.94万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 61.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 61.94万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 61.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 61.94万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 61.94万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 61.94万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 61.94万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 61.94万 - 项目类别:
Standard Grant